脑部放疗，上午比下午敏感许多！. p% c" g7 y$ w. T/ _( L
B1 k" _ v% D6 S; ~& H, P1 p
" l( a4 Y9 N3 ~8 u! |: sCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
1 V/ U6 F: [) v. `: T: [$ r* kGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?0 V/ Y& V0 e8 ]! z
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
8 @& Z% y4 \0 U1 w8 {1 _SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.' o \; F9 C7 q# V
. C& K5 c2 y; k, G7 X
Abstract$ T. D0 J" v0 \. @4 j
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.+ e* Y n v& ?+ f& ^' @
5 ]' |# B7 [7 H8 c# FMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
4 \3 v+ V. |9 c. V5 n- I2 Q
, w/ D% r3 h3 m* W$ t9 Y8 v" _RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).% o& h4 {4 p3 K: J0 b2 ~: _2 K/ e; D
6 D. E$ O! C" ?# G+ }CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
; p: ^8 ]. A/ F: c/ H* i9 l6 c, S5 Y
|
) ~* n5 \' T) \; m/ H; ^4 e
显身卡
